KazSMO
Educational
Intensive

Three days of an educational course

An educational platform of the Kazakh School of Medical Oncology (KazSMO) and KazIOR: evidence-based medicine, international clinical guidelines and multidisciplinary patient management in practice.

Hands-on sessions focused on current clinical and research skills. Registration for each workshop is separate and paid (see the Registration section).

Workshops run on 17 November and masterclasses on 18 November, in parallel with the main programme. Registration for each is separate and paid.

Eight course topics

Particular attention is given to molecular diagnostics, personalised therapy, modern targeted and immuno-oncology drugs, patient routing, and the prevention and management of adverse events. More than 200 medical oncologists, chemotherapists, surgical oncologists, radiation oncologists, radiologists and pathologists from every region of Kazakhstan and from abroad are expected.

Registration

Invited experts

Woo Jin Hyung, MD, Professor

Professor of Surgery · Yonsei University College of Medicine

Surgical Management of Gastric Cancer

Daniele Regge, MD, Professor

Director of the Artificial Intelligence for Medical Imaging Lab · Istituto Nazionale Oncologico Candiolo

Screening for lung cancer: where we stand and where are we going?

Hasan Fevzi Batirel, MD, PhD

President, European Society of Thoracic Surgeons · Memorial Goztepe Hospital

Changing Trends in the Treatment of Locally Advanced Non-Small Cell Lung Cancer

Javier Garde, MD

Valencian Institute of Oncology

Systemic Therapy for Driver Mutation-Negative Lung Cancer

Masahiro Nakashima, MD, PhD, Professor

Director; Head of the Department of Tumor and Diagnostic Pathology · Atomic Bomb Disease Institute; Nagasaki University

Thyroid Cancer Pathology: From Morphology to Molecular Diagnosis

Mikael Hartman, MD, Associate Professor

Senior Consultant · NUS Yong Loo Lin School of Medicine; NUS Saw Swee Hock School of Public Health; Breast and Trauma Surgery, Department of Surgery, National University Hospital

Next generation Breast Cancer Screening

Samuel Ow, MD, M.Med, MPH, Associate Professor

Department of Medicine, Yong Loo Lin School of Medicine; Senior Consultant, Department of Haematology-Oncology · National University of Singapore; National University Cancer Institute

Systemic Therapy for Early Breast Cancer

Kaldygul Smagulova, Candidate of Medical Sciences (PhD), Associate Professor

Head of the Chemotherapy Day Hospital Department · Kazakh Institute of Oncology and Radiology

Systemic Therapy: Advanced Breast Cancer

Zhanar Abdrasilova, MD

Kazakh Institute of Oncology and Radiology

LDCT Screening for Lung Cancer in KZ: Interpretation and Standardized Reporting

speaker photo

Sinan Karaaslan, MD

Anadolu Medical Center

Systemic Therapy for Gastric Cancer

speaker photo

Banu Atalar, MD

Radiation Therapy for Lung Cancer

speaker photo

Hirokazu Kurohama, MD, PhD, Assistant Professor

Medical Director, Department of Tumor and Diagnostic Pathology · Atomic Bomb Disease Institute; Nagasaki University

Pathology of Lung Cancer: From Histological Diagnosis to Biomarker Testing

speaker photo

Ashutosh Mishra, MD, FACS, FSSO, Fellow-ESSO, Fellow UICC; MS, FAIS, FMAS, FIAGES, FARIS; MBA, Associate Professor

Department of Surgical Oncology · Dr. BRA-IRCH & National Cancer Institute (NCI); All India Institute of Medical Sciences (AIIMS)

Surgical Management of Breast Cancer

speaker photo

Nazgul Omarbayeva, MD

Kazakh Institute of Oncology and Radiology

Treatment Decision According to Molecular Features

speaker photo

Thomas Mulliez, MD, Professor

Radiation oncologist · AZ Delta; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel

Radiation Therapy for Breast Cancer

speaker photo

Ramil Abdrakhmanov, MD, PhD, Associate Professor

Head, Chemotherapy Center · Kazakh Institute of Oncology and Radiology

Bispecific Antibodies in EGFR-Mutant NSCLC: Shifting the Therapeutic Paradigm

speaker photo

Aliya Turesheva, MD, PhD

Chair of the Multidisciplinary Tumor Board · Almaty Oncology Center

Beyond TKI Monotherapy: Redefining First-Line Treatment in EGFR-Mutant NSCLC

speaker photo

Rabiga Kadyrbayeva, MD, PhD (C)

Medical Oncologist, Chemotherapy Day Hospital; ESO-trained in Thoracic Oncology · Kazakh Institute of Oncology and Radiology

Perioperative Immunotherapy in Resectable NSCLC: From Patient Selection to Treatment Strategy - A Case-Based Approach

speaker photo

Valeriy Makarov, MD, PhD

Thoracic Oncologic Surgeon, Senior Physician, Thoracic Oncosurgery Unit · National Research Oncology Center, Astana

Rebiopsy in NSCLC: From Molecular Need to Surgical Decision-Making

speaker photo

Assel Issimbayeva, MD

Medical Oncologist, Chemotherapy Department No. 1 · Multidisciplinary Medical Center, Astana

Immune-Related Adverse Events in Lung Cancer: Recognition, Management, and Rechallenge

speaker photo

Lorenza Landi, MD

Medical Oncologist; Director, Clinical Trials Unit · IRCCS Regina Elena National Cancer Institute, Rome

speaker photo

Gulzhanat Kaidarova

Kazakhstan

Abemaciclib in Combination with Endocrine Therapy: The Next Steps in the Treatment of High-Risk Early Breast Cancer

speaker photo

Elvira Satbayeva

Satellite Symposium: Advancing Treatment in EGFR-Mutant NSCLC: From Targeted Therapy to Personalized Treatment Strategies

speaker photo

K.M. Ormanov

Satellite Symposium: Advancing Treatment in EGFR-Mutant NSCLC: From Targeted Therapy to Personalized Treatment Strategies

The speaker list is being extended — leading experts from major clinics in the United Kingdom, Spain and Türkiye are expected.

KazIOR, Almaty